Free Trial

KalVista Pharmaceuticals (KALV) Short Interest Ratio & Short Volume

KalVista Pharmaceuticals logo
$11.42 -0.45 (-3.79%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$11.56 +0.14 (+1.26%)
As of 09:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

KalVista Pharmaceuticals Short Interest Data

KalVista Pharmaceuticals (KALV) has a short interest of 5.86 million shares. This marks a -5.64% decrease in short interest from the previous month. The short interest ratio (days to cover) is 9.9, indicating that it would take 9.9 days of the average trading volume of 420,654 shares to cover all short positions.

Current Short Interest
5,860,000 shares
Previous Short Interest
6,210,000 shares
Change Vs. Previous Month
-5.64%
Dollar Volume Sold Short
$80.69 million
Short Interest Ratio
9.9 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
49,716,000 shares
Percentage of Shares Shorted
11.79%
Today's Trading Volume
549,287 shares
Average Trading Volume
420,654 shares
Today's Volume Vs. Average
131%
Short Selling KalVista Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

KALV Short Interest Over Time

KALV Days to Cover Over Time

KALV Percentage of Float Shorted Over Time

KalVista Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20255,860,000 shares $80.69 million -5.6%N/A9.9 $13.77
4/15/20256,210,000 shares $74.64 million +6.0%14.0%11.2 $12.02
3/31/20255,860,000 shares $67.62 million +0.3%13.2%11.2 $11.54
3/15/20255,840,000 shares $73.58 million +5.4%13.2%12.9 $12.60
2/28/20255,540,000 shares $63.16 million -5.0%12.5%13.3 $11.40
2/15/20255,830,000 shares $56.90 million -18.2%13.2%15.7 $9.76
1/31/20257,130,000 shares $63.53 million -6.1%N/A19.3 $8.91
1/15/20257,590,000 shares $59.66 million +1.9%N/A21 $7.86
12/31/20247,450,000 shares $63.10 million +3.8%N/A21.5 $8.47
12/15/20247,180,000 shares $62.39 million -1.1%N/A17.8 $8.69
11/30/20247,260,000 shares $73.04 million -1.5%N/A17.6 $10.06
11/15/20247,370,000 shares $69.94 million +7.3%N/A17.7 $9.49
10/31/20246,870,000 shares $70.55 million +0.9%N/A19 $10.27
10/15/20246,810,000 shares $81.58 million +4.6%N/A20.1 $11.98
9/30/20246,510,000 shares $75.39 million +13.8%N/A17 $11.58
9/15/20245,720,000 shares $63.72 million +1.2%N/A15.6 $11.14
8/31/20245,650,000 shares $75.65 million -0.5%N/A17.4 $13.39
8/15/20245,680,000 shares $72.65 million -5.0%N/A17.9 $12.79
7/31/20245,980,000 shares $86.95 million -5.5%N/A18.3 $14.54
7/15/20246,330,000 shares $94.70 million +7.7%N/A18.4 $14.96
6/30/20245,880,000 shares $69.27 million +4.3%N/A17.7 $11.78
6/15/20245,640,000 shares $68.07 million +2.2%N/A15.4 $12.07
5/31/20245,520,000 shares $64.42 million -4.2%N/A14.1 $11.67
5/15/20245,760,000 shares $69.18 million +4.0%N/A11.7 $12.01
4/30/20245,540,000 shares $62.88 million -4.8%N/A7.4 $11.35
4/15/20245,820,000 shares $68.33 million +5.4%N/A7.3 $11.74
3/31/20245,520,000 shares $65.47 million +12.2%N/A6.8 $11.86
3/15/20244,920,000 shares $58.70 million +9.1%N/A6.4 $11.93
2/29/20244,510,000 shares $61.56 million +50.8%18.6%5.9 $13.65
2/15/20242,990,000 shares $44.13 million +21.1%12.4%4.4 $14.76
1/31/20242,470,000 shares $38.95 million -10.5%12.9%6.1 $15.77
1/15/20242,760,000 shares $35.77 million -25.2%14.2%8.3 $12.96
12/31/20233,690,000 shares $45.20 million +5.7%18.7%11.8 $12.25
12/15/20233,490,000 shares $37.27 million -9.6%16.7%10.8 $10.68
11/30/20233,860,000 shares $32.58 million -3.5%18.2%13.4 $8.44
11/15/20234,000,000 shares $30.76 million -3.4%19.0%13.9 $7.69
10/31/20234,140,000 shares $35.15 million -10.8%17.3%14.8 $8.49
10/15/20234,640,000 shares $42.13 million +4.7%N/A16.9 $9.08
9/30/20234,430,000 shares $42.66 million +9.1%N/A16.9 $9.63
9/15/20234,060,000 shares $39.87 million +4.6%N/A19.4 $9.82
Watch This Robotics Demo Before July 23rd (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

8/31/20233,880,000 shares $42.10 million -5.4%N/A19.1 $10.85
8/15/20234,100,000 shares $44.32 million +2.8%19.7%21.4 $10.81
7/31/20233,990,000 shares $40.30 million +2.3%18.3%21 $10.10
7/15/20233,900,000 shares $37.60 million +3.7%17.9%21 $9.64
6/30/20233,760,000 shares $33.84 million +0.8%17.3%18.5 $9.00
6/15/20233,730,000 shares $35.92 million +3.9%17.2%17.2 $9.63
5/31/20233,590,000 shares $35.00 million +5.0%16.5%14.6 $9.75
5/15/20233,420,000 shares $34.58 million +4.3%15.8%12.6 $10.11
4/30/20233,280,000 shares $27.98 million +17.1%14.0%11.5 $8.53
4/15/20232,800,000 shares $22.15 million +3.3%12.0%8.7 $7.91
3/31/20232,710,000 shares $21.30 million +10.2%11.6%8 $7.86
3/15/20232,460,000 shares $18.33 million +13.4%N/A7 $7.45
2/28/20232,170,000 shares $15.91 million -19.6%N/A6.3 $7.33
2/15/20232,700,000 shares $20.87 million -0.4%N/A8.6 $7.73
1/31/20232,710,000 shares $21.57 million +26.6%N/A8.9 $7.96
1/15/20232,140,000 shares $15.19 million -10.5%N/A6.7 $7.10
12/30/20222,390,000 shares $16.16 million +14.9%10.2%7.4 $6.76
12/15/20222,080,000 shares $11.90 million No Change10.4%4.7 $5.72
11/30/20222,080,000 shares $11.21 million No Change10.4%5.1 $5.39
11/15/20222,080,000 shares $10.86 million -8.8%10.4%5.1 $5.22
10/31/20222,280,000 shares $11.56 million -0.4%10.9%5.5 $5.07
10/15/20222,290,000 shares $10.44 million -10.2%10.9%6.2 $4.56
9/30/20222,550,000 shares $37.00 million +3.7%12.2%7.7 $14.51
9/15/20222,460,000 shares $36.43 million +4.7%11.8%13.2 $14.81
8/31/20222,350,000 shares $38.70 million +14.6%11.2%10.7 $16.47
8/15/20222,050,000 shares $32.41 million +8.5%9.8%7.3 $15.81
7/31/20221,890,000 shares $23.34 million +2.7%9.0%6.1 $12.35
7/15/20221,840,000 shares $22.69 million +3.4%8.7%5.7 $12.33
6/30/20221,780,000 shares $17.52 million -16.8%8.5%5.3 $9.84
6/15/20222,140,000 shares $19.07 million +58.5%10.2%6.4 $8.91
5/31/20221,350,000 shares $12.00 million +7.1%6.4%4.6 $8.89
5/15/20221,260,000 shares $12.23 million +37.7%6.0%5.4 $9.71
4/30/2022914,800 shares $11.65 million +4.6%4.3%4.4 $12.73
4/15/2022874,800 shares $12.56 million -19.7%4.2%4.2 $14.36
3/31/20221,090,000 shares $16.07 million -17.4%5.2%5.2 $14.74
3/15/20221,320,000 shares $19.14 million +1.5%6.3%6.6 $14.50
2/28/20221,300,000 shares $20.87 million +13.0%6.2%6.3 $16.05
2/15/20221,150,000 shares $18.95 million -5.7%5.5%5 $16.48
1/31/20221,220,000 shares $15.40 million +15.1%5.8%5.7 $12.62
1/15/20221,060,000 shares $13.29 million +11.9%5.0%5 $12.54
12/31/2021947,400 shares $12.53 million +0.4%4.5%4.7 $13.23
12/15/2021943,800 shares $12.81 million -2.2%4.2%4.4 $13.57
11/30/2021964,800 shares $13.99 million -6.3%4.3%4.4 $14.50
11/15/20211,030,000 shares $17.94 million -5.5%4.6%5.4 $17.42
10/29/20211,090,000 shares $19.60 million -11.4%4.9%5.8 $17.98
10/15/20211,230,000 shares $21.17 million +3.4%5.5%6.9 $17.21
9/30/20211,190,000 shares $20.77 million -14.4%5.4%6.5 $17.45
9/15/20211,390,000 shares $26.76 million -21.0%6.2%7 $19.25
8/31/20211,760,000 shares $35.97 million -4.9%7.9%8.7 $20.44
8/13/20211,850,000 shares $35.72 million -4.2%8.3%8.6 $19.31
Watch This Robotics Demo Before July 23rd (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

7/30/20211,930,000 shares $38.87 million -1.5%9.5%8.5 $20.14
7/15/20211,960,000 shares $43.04 million -2.0%9.9%7.7 $21.96
6/30/20212,000,000 shares $47.92 million +39.9%10.1%6.7 $23.96
6/15/20211,430,000 shares $40.78 million +3.6%7.2%4.6 $28.52
5/28/20211,380,000 shares $37.26 million -3.5%7.0%4.2 $27.00
5/14/20211,430,000 shares $35.91 million +6.7%N/A3.9 $25.11
4/30/20211,340,000 shares $33.81 million +3.1%N/A1.2 $25.23
4/15/20211,300,000 shares $32.40 million +10.2%N/A1.2 $24.92
3/31/20211,180,000 shares $30.33 million +51.8%N/A1.2 $25.70
3/15/2021777,400 shares $25.27 million -0.6%N/A0.8 $32.50
2/26/2021782,400 shares $25.99 million +22.0%N/A0.9 $33.22
2/12/2021641,100 shares $25.93 million +25.0%3.8%0.7 $40.45
1/29/2021513,100 shares $8.02 million +28.2%4.5%0.8 $15.64
1/15/2021400,200 shares $6.88 million +4.7%3.5%3.3 $17.18
12/31/2020382,400 shares $7.22 million +27.3%3.4%3.2 $18.89
12/15/2020300,300 shares $5.69 million -11.6%2.7%3 $18.95
11/30/2020339,700 shares $6.61 million +3.9%3.0%3.8 $19.47
11/15/2020326,900 shares $6.15 million +47.0%2.8%3.8 $18.80
10/30/2020222,400 shares $3.83 million -12.3%1.9%2.9 $17.22
10/15/2020253,600 shares $3.79 million +2.3%2.2%3.7 $14.95
9/30/2020247,900 shares $3.12 million -16.4%2.1%3.8 $12.59
9/15/2020296,600 shares $4.12 million -7.1%2.5%3.4 $13.88
8/31/2020319,100 shares $4.18 million -10.6%2.7%2.6 $13.10
8/14/2020356,900 shares $4.53 million -9.2%2.8%2.8 $12.70
7/31/2020392,900 shares $3.86 million -8.7%3.1%2.9 $9.83
7/15/2020430,200 shares $4.97 million +9.8%3.4%3.2 $11.56
6/30/2020391,800 shares $4.74 million +24.2%3.1%2.8 $12.10
6/15/2020315,500 shares $3.28 million -7.5%2.5%2.3 $10.40
5/29/2020341,200 shares $3.71 million +1.2%2.7%2.6 $10.86

KALV Short Interest - Frequently Asked Questions

What is KalVista Pharmaceuticals' current short interest?

Short interest is the volume of KalVista Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 5,860,000 shares of KALV short. Learn More on KalVista Pharmaceuticals' current short interest.

What is a good short interest ratio for KalVista Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KALV shares currently have a short interest ratio of 10.0. Learn More on KalVista Pharmaceuticals's short interest ratio.

Is KalVista Pharmaceuticals' short interest increasing or decreasing?

KalVista Pharmaceuticals saw a decline in short interest in April. As of April 30th, there was short interest totaling 5,860,000 shares, a decline of 5.6% from the previous total of 6,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does KalVista Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to KalVista Pharmaceuticals: Xenon Pharmaceuticals Inc. (4.67%), Amneal Pharmaceuticals, Inc. (4.44%), HUTCHMED (China) Limited (0.24%), Organon & Co. (7.61%), Mirum Pharmaceuticals, Inc. (12.58%), Apellis Pharmaceuticals, Inc. (22.89%), Arrowhead Pharmaceuticals, Inc. (9.80%), Vericel Co. (9.18%), NewAmsterdam Pharma (8.68%), Belite Bio, Inc (0.23%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short KalVista Pharmaceuticals stock?

Short selling KALV is an investing strategy that aims to generate trading profit from KalVista Pharmaceuticals as its price is falling. KALV shares are trading down $0.45 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against KalVista Pharmaceuticals?

A short squeeze for KalVista Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KALV, which in turn drives the price of the stock up even further.

How often is KalVista Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALV, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:KALV) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners